文献速递腹部技术与安全CT

新辅助FOLFIRINOX后手术的胰腺导管腺癌患者复发与总生存的重要CT及组织病理学表现

Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after neoadjuvant FOLFIRINOX.
PubMed 文献 · Eur Radiol · 2020-11-17

回顾性纳入69例接受新辅助FOLFIRINOX后手术的胰腺导管腺癌患者,基于基线和首次随访CT评估影像表现及可切除性,并分析组织病理学结果。基线CT上的胰腺外神经侵犯(EPNI)和肿瘤退缩分级(TRG)是早期复发的重要预测因素,TRG也是总生存的重要预后因素。

要点

  • 基线CT评估的胰腺外神经侵犯(EPNI)与早期复发相关(HR 2.53,p=0.026)。
  • 组织病理学肿瘤退缩分级(TRG)是早期复发(HR 1.76,p=0.046)和总生存(HR 1.05,p=0.013)的重要预后因素。
  • CT表现未能独立预测残留肿瘤(R1/R2)。

诊断标准与关键数值

  • 基线CT上EPNI预测无复发生存期(RFS)的HR为2.53(95%CI 1.116-5.733,p=0.026)。
  • TRG预测RFS的HR为1.76(95%CI 1.000-3.076,p=0.046)。
  • TRG预测总生存期(OS)的HR为1.05(95%CI 1.251-6.559,p=0.013)。
  • R0切除57例(82.6%),R1或R2切除12例(17.4%)。

临床应用与阅片要点

  • 作者认为基线CT评估的EPNI和TRG有助于预测早期复发和不良生存。
  • CT表现未发现可独立预测残留肿瘤的因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate important factors for recurrence-free survival (RFS) and overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDA) who underwent surgery after neoadjuvant FOLFIRINOX using CT and histopathological findings.

MATERIALS AND METHODS: Sixty-nine patients with PDA who underwent surgery after neoadjuvant FOLFIRINOX were retrospectively included. All patients underwent baseline and first follow-up CT. Two reviewers assessed the CT findings and resectability based on the NCCN guideline. They graded extrapancreatic perineural invasion (EPNI) using a 3-point scale focused on 5 routes. Clinical and histopathological results, such as T- and N-stage, tumor regression grade (TRG) using the College of American Pathology (CAP) grading system, and resection status, were also investigated. Kaplan-Meier methods were used for RFS and OS. The Cox proportional hazard model and logistic regression model were used to identify significant predictive factors.

RESULTS: There were 57 patients (82.6%) without residual tumors (R0) and 12 patients (17.4%) with residual tumors (R1 or R2). The median RFS was 13 months (range 0~22 months). For RFS, EPNI on baseline CT (hazard ratio (HR) 2.53, 95% confidence interval (CI) 1.116-5.733, p = 0.026) and TRG (HR 1.76, 95% CI 1.000-3.076, p = 0.046) were important predictors of early recurrence. The mean OS was 48 months (range 11~35 months). For OS, TRG (HR 1.05, 95% CI 1.251-6.559, p = 0.013) was a significant factor. However, there were no independent predictors for residual tumors according to the CT findings.

CONCLUSION: EPNI on baseline CT and TRG were important prognostic factors for tumor recurrence. In addition, TRG was also an important prognostic factor for OS.

KEY POINTS: • CT and histopathological findings are helpful for predicting early recurrence and poor survival. • EPNI on baseline CT (HR 2.53, p = 0.026) is an important predictor of early recurrence. • The TRG is an important prognostic factor for early recurrence (HR 1.76, p = 0.046) and poor survival (HR 1.05, p = 0.013).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park SJ, Kim JH, Joo I, et al. Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after neoadjuvant FOLFIRINOX. Eur Radiol. 2020. PMID: 33201279. doi:10.1007/s00330-020-07489-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。